One of the largest manufacturers of generic oxycodone will be required to monitor sales of its product from distributors to independent pharmacies and pain clinics, under a settlement agreement with the U.S. Department of Justice. Mallinckrodt LLC will pay $35 million to settle allegations that it failed to detect and notify the Drug Enforcement Administration of suspicious orders... Read More